Orion Pharma at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
Orion Pharma brings 2 presentations to SITC 2026 in Phoenix. Its program centres on blocking immune-suppressing pathways in preclinical mouse tumor models. It reports stronger immune activation and tumor control when PVRIG and PD-L1 are blocked at the same time.
| Organization | SITC 2026 Attendance |
|---|---|
Orion Pharma Espoo, Finland | |
A pharmaceutical company developing and marketing medicines, including oncology therapies. | Poster Fri Nov 6 12:15–1:45pm 5:30–7pm |
Instantly find 20 buyers from Orion Pharma
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction